Key facts
- It has raised $67.0M across 2 recorded rounds; the latest was Early Stage VC ($37.1M) in Dec 2025.
- Notable investors include Northern Light Venture Capital, Supernova Invest, Andera Partners, Omega Funds, Hero Enterprise — 7 tracked in total.
- Spiro Medical has filed 3 Form Ds with the SEC since 2023, most recently Jun 2024 ($500K sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Spiro Medical
Funding rounds
2 roundsAbout Spiro Medical
Developer of respiratory and sleep-care equipment designed to equip clinics and patients with diagnostic and therapeutic devices. The company platform offers devices including pulse oximeters, cardio-respiratory monitors, polysomnography systems, and bilevel positive airway pressure units, oxygen-therapy equipment, and full diagnostic/therapeutic suites for sleep-apnea and chronic respiratory insufficiency, enabling healthcare facilities and individuals to diagnose, monitor, and treat respiratory and sleep disorders.
- Sector
- Healthcare
- HQ
- Belleair Bluffs, FL, United States
- Founded
- 2023
- Website
- spiro-medical.com/
- Ownership
- Privately Held (backing)
Spiro Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Spiro Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Spiro Medical in its N-PORT filings yet. We sweep new filings monthly.